Glycologix, Inc. — Form D

Glycologix, Inc. of BEVERLY, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-09. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Other Technology.

Offering

Filed: 2024-04-09
Form: D
Accession: 0001903671-24-000001
Industry: Other Technology
Exemptions: 06b
Total offering: $1.5M
Amount sold: $1.5M
Minimum investment: $5K
Investors: 48
Date of first sale: 2024-04-05
Security types: equity
Revenue range: No Revenues
SEC file number: 021-510098

Issuer

Name: Glycologix, Inc.
CIK: 0001903671
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 100 CUMMINGS CENTER, SUITE 451C, BEVERLY, MA, 01915
Phone: 6174802536

Officers, directors & promoters (7)

Name	Role	Location
Douglas Smith	Executive Officer	San Francisco, CA
Michael Chester	Director	Santa Monica, CA
George Adaniya	Director	Beverly, MA
Daniel Deardorf	Director	Beverly, MA
Daniel Deardorf	Executive Officer	Beverly, MA
Martha Farmer	Director	Beverly, MA
Michael Marsh	Director	TRAVERSE CITY, MI

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2025-12-29	D	$1.0M	$800K
2023-05-23	D	$1.8M	$1.1M
2022-01-10	D	$3.0M	$1.8M

More